Cas:20567-38-8 4,5-dimethoxy-2-nitrocinnamic acid manufacturer & supplier

Chemical Name:4,5-dimethoxy-2-nitrocinnamic acid

CAS.NO:20567-38-8

Synonyms:4,5-Dimethoxy-2-nitrociamic acid;6-Nitro-3.4-dimethoxy-trans-zimtsaeure;4,5-Dimethoxy-2-nitrocinnamic acid;3-(4,5-DIMETHOXY-2-NITROPHENYL)ACRYLIC ACID;6-nitro-3.4-dimethoxy-trans-cinnamic acid;2-Nitro-4,5-dimethoxy-trans-cinnamic acid;6-nitro-3,4-dimethoxycinnamic acid;RARECHEM BK HW 0176;2-nitro-4,5-dimethoxycinnamic acid;3,4-DIMETHOXY-6-NITROCINNAMIC ACID;MFCD00017017

Molecular Formula:C₁₁H₁₁NO₆

Molecular Weight:253.20800

HS Code:2918990090

Physical and Chemical Properties:

Melting point:293 °C (dec.)(lit.)

Boiling point:482.9ºC at 760mmHg

Density:1.369g/cm3

Index of Refraction:1.604

PSA:101.58000

Exact Mass:253.05900

LogP:2.23300

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 4,5-Dimethoxy-2-nitrociamic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00017017 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,RARECHEM BK HW 0176 Use and application,6-nitro-3,4-dimethoxycinnamic acid technical grade,usp/ep/jp grade.

Related News: It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing. 4,5-dimethoxy-2-nitrocinnamic acid manufacturer In approving the first new Alzheimer’s drug in nearly 20 years, the U.S. Food and Drug Administration is taking its biggest risk yet with a strategy that allows new therapies onto the market without strong evidence that they work, regulatory and scientific experts say. 4,5-dimethoxy-2-nitrocinnamic acid supplier On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks. 4,5-dimethoxy-2-nitrocinnamic acid vendor It is understood that at present, the industry competition for global characteristic APIs has shown a development trend of vertical integration, and the number of mergers and acquisitions between pharmaceutical manufacturers and API manufacturers is increasing. 4,5-dimethoxy-2-nitrocinnamic acid factory The Company selected the top-performing clone for generation of the master engineered iPSC bank for GMP production of FT819.